Shenzhen U-Bio-Tech Co., Ltd.
To all Shareholders and Shareholder Representatives:
As an independent director of the fifth board of directors of Shenzhen U-Bio-Tech Co., Ltd. (hereinafter referred to as the "Company"), I, in accordance with the "Company Law," "Securities Law," "Shenzhen Stock Exchange GEM Stock Listing Rules," "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 2 - Norms for the Operation of GEM Listed Companies," "Administrative Measures for Independent Directors of Listed Companies," and the "Company Articles of Association," and the Company's "Independent Director Work System," and other relevant laws, regulations, and requirements, have diligently, conscientiously, and faithfully performed my duties, actively and punctually attended relevant meetings, conscientiously reviewed all proposals submitted to the board of directors, expressed independent opinions on relevant matters of the Company, and effectively protected the interests of the Company and shareholders. I hereby report to all shareholders on my performance of duties as an independent director in 2025:
I. Basic Information of Independent Directors
I, Wu Yuejuan, born in 1964, hold a Master of Laws degree from Renmin University of China. Since October 2021, I have served as a director of Shenzhen Kexin Communication Technology Co., Ltd. Since October 2022, I have served as an independent director of Shenzhen Bati Ecological Engineering Co., Ltd. I have served as an independent director of the Company since December 27, 2021.
In accordance with the "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 2 - Norms for the Operation of GEM Listed Companies," and other relevant regulations, I have self-inspected whether I meet the independence requirements during the reporting period and submitted a self-inspection report to the Company's board of directors. Through self-inspection, my position meets the independence requirements for independent directors stipulated in the relevant regulations, and there are no circumstances that affect my independence.
II. Annual Performance and Key Areas of Focus
- Attendance at Board and Shareholder Meetings
In 2025, I strictly adhered to the requirements of relevant laws and regulations and diligently performed my duties, with no instances of absence from board meetings. The meeting attendance is as follows:
| Independent Director Name | Total Scheduled Attendance | Actual Attendance | Attendance via Communication | Attendance via Entrustment | Absence | Whether Consecutive Two Meetings Unattended in Person | Attendance at Shareholder Meetings |
|---|---|---|---|---|---|---|---|
| Wu Yuejuan | 7 | 1 | 6 | 0 | 0 | No | 3 |
The convening and holding of the Company's board meetings and shareholder meetings in 2025 complied with legal procedures. I have conscientiously reviewed all proposals submitted to the board of directors, and I believe that these proposals did not harm the interests of all shareholders, especially small and medium shareholders, and therefore I voted in favor of all of them, with no opposing or abstaining votes.
- Participation in Board Special Committees and Independent Director Special Meetings
(1) Board Audit Committee